Phl0x Pharma Limited - Company Profile

It is a chemicals public limited company based in Hyderabad., Telangana, India, established in 1995.
1995 Hyderabad., Telangana, India Struck Off
Last Updated:
Access Report
About Phl0x Pharma Limited

Phl0x Pharma Limited, a struck off public limited company, was established on 15 September 1995 in Hyderabad., Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230TG1995PLC021729. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹0.51 M.

Its leadership includes Majgaonkar Deepak Manasi (Director), Deepak Vaman Majgaonkar (Director), Jyothi Ganti (Director). Its latest AGM occurred on 30 September 2008, with the balance sheet filed on 31 March 2008. It is based at C-9, Madhura Nagar,Hyderabad. Hyderabad., Hyderabad., Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1995PLC021729

  • Registration Number

    021729

  • Incorporation Date

    15 September 1995

  • Authorized Capital

    ₹6.00 M

  • Paid-Up Capital

    ₹0.51 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 0.51 M
  • Company Age 30 Year, 7 Months
  • Last Filing with ROC 31 Mar 2008
Company report

Phl0x Pharma Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Phl0x Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Phl0x Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Majgaonkar Deepak Manasi Director 12 Oct 1998 Current
Deepak Vaman Majgaonkar Director 15 Sep 1995 Current
Jyothi Ganti Director 12 Oct 1998 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Phl0X Pharma.

Enhance accessibility to Phl0X Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Phl0X Pharma revenue growth over time
Phl0X Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Phl0X Pharma?

Unlock access to Phl0X Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Phl0X Pharma?

Unlock and access historical data on people associated with Phl0X Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Phl0X Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phl0X Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Phl0X Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Phl0X Pharma Limited last Annual general meeting of members was held on 30 Sep 2008 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Phl0X Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Majgaonkar Deepak Manasi was appointed as a Director was appointed as a Director on 12 Oct 1998 & has been associated with this company since 27 years 6 months . was documented.

  • Director Appointment

    The activity Jyothi Ganti was appointed as a Director was appointed as a Director on 12 Oct 1998 & has been associated with this company since 27 years 6 months . was completed.

  • Director Appointment

    Deepak Vaman Majgaonkar was appointed as a Director was appointed as a Director on 15 Sep 1995 & has been associated with this company since 30 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Phl0X Pharma Limited was registered on 15 Sep 1995 with Roc Hyderabad & aged 30 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Phl0x Pharma Limited?

The CIN of Phl0x Pharma Limited is U24230TG1995PLC021729.

Where is Phl0x Pharma Limited headquartered?

Phl0x Pharma Limited is headquartered at C-9, Madhura Nagar,Hyderabad. Hyderabad., Hyderabad., Telangana, 500039.

When was Phl0x Pharma Limited incorporated?

Phl0x Pharma Limited was incorporated on 15 September 1995.

Who are the current directors of Phl0x Pharma Limited?

The current directors of Phl0x Pharma Limited are

What is the primary industry of Phl0x Pharma Limited?

The primary industry of Phl0x Pharma Limited is Chemicals.

Is Phl0x Pharma Limited a listed company?

Phl0x Pharma Limited is unlisted.

What is the capital structure of Phl0x Pharma Limited?

The authorized capital of Phl0x Pharma Limited is ₹6.00 M, and the paid-up capital is ₹0.51 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available